AGF Investments Inc’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,823
Closed -$368K 758
2021
Q3
$368K Sell
2,823
-16,769
-86% -$2.53M ﹤0.01% 501
2021
Q2
$3.48M Buy
19,592
+16,911
+631% +$2.93M 0.03% 271
2021
Q1
$441K Sell
2,681
-68
-2% -$11.2K ﹤0.01% 503
2020
Q4
$454K Sell
2,749
-270
-9% -$40.2K ﹤0.01% 482
2020
Q3
$430K Buy
3,019
+660
+28% +$81.8K ﹤0.01% 463
2020
Q2
$260K Sell
2,359
-225
-9% -$24.9K ﹤0.01% 592
2020
Q1
$258K Buy
+2,584
New +$334K ﹤0.01% 502
2018
Q4
Sell
-458,755
Closed -$77.1M 375
2018
Q3
$77.1M Buy
458,755
+4,051
+0.9% +$697K 0.78% 48
2018
Q2
$78.3M Buy
+454,704
New +$74.3M 0.81% 39
2015
Q3
Sell
-100
Closed -$18K 468
2015
Q2
$18K Sell
100
-70,997
-100% -$12.8M ﹤0.01% 406
2015
Q1
$12.3M Hold
71,097
0.13% 160
2014
Q4
$11.6M Hold
71,097
0.12% 165
2014
Q3
$11.4M Hold
71,097
0.12% 174
2014
Q2
$10.5M Hold
71,097
0.1% 193
2014
Q1
$9.86M Hold
71,097
0.1% 193
2013
Q4
$9.01M Sell
71,097
-6,300
-8% -$652K 0.09% 198
2013
Q3
$7.1M Hold
77,397
0.08% 204
2013
Q2
$5.32M Buy
+77,397
New +$4.73M 0.06% 220

Other funds holding JAZZ

AGF Investments Inc's JAZZ Position: Q4 2021 in Review

AGF Investments Inc sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2021, closing a stake of 2,823 shares — an estimated $368K sold.

AGF Investments Inc first reported a position in JAZZ in Q2 2013 and held it in 18 quarters. The position peaked at $78.3M in Q2 2018. 454 funds tracked by Wall St. Rank hold JAZZ as of Q4 2021.

  • AGF Investments Inc reported no remaining Jazz Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • AGF Investments Inc sold 2,823 Jazz Pharmaceuticals shares in Q4 2021, an estimated $368K.
  • AGF Investments Inc first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • AGF Investments Inc's Jazz Pharmaceuticals position peaked at $78.3M in Q2 2018.
  • 454 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2021.

Based on AGF Investments Inc's 13F filing for Q4 2021, filed 1 Feb 2022.